Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Comment by DIYGuyon Dec 07, 2017 12:46pm
82 Views
Post# 27110469

RE:Bring Danter back!

RE:Bring Danter back! I do not expect to see Danter back, but would love to know how many shares he still has.

Maybe they wanted to get the trial results out and they were delayed beyond the meeting. Cancelled at last second could suggest the votes weren’t there, but I seriously doubt that.

Surprised to see no volume at all on the cancelled meeting. For a brief moment the sellers have decided not to throw away their shares. No one making any money selling at $1.05. Would love to see us get back to $1.50 which is where I thought we would hold after the consolidation.
<< Previous
Bullboard Posts
Next >>